In
accordance with the Act for the Development of Biotech and Pharmaceutical
Industry, Calgent received the “Biotech New Drug Company” designation from
the Ministry of Economic Affairs (MOEA), Taiwan to dramatically boost the
innovative R&D and manufacturing for CAL056.
